Related Experiment Video
Updated: Jan 21, 2026

Using an Automated Hirschberg Test App to Evaluate Ocular Alignment
Published on: March 24, 2020
Ozone Inhibits APP/Aβ Production and Improves Cognition in an APP/PS1 Transgenic Mouse Model.
Si-Yu Lin1, Jun Ma1, Jian-Xiong An1
1Department of Anesthesiology, Pain Medicine & Critical Care Medicine, Aviation General Hospital of China Medical University & Beijing Institute of Translational Medicine, Chinese Academy of Sciences, Beiyuan Rd 3#, Beijing, 100012, China.
Ozone therapy may offer a new treatment for Alzheimer's disease (AD). Studies show ozone injections improved memory and reduced key Alzheimer's disease markers in mice.
Area of Science:
- Neuroscience
- Pharmacology
- Gerontology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder with no effective treatments.
- Amyloid-beta (Aβ) peptide production and deposition are central to AD pathology.
- Investigating novel therapeutic interventions for AD is crucial.
Purpose of the Study:
- To investigate the therapeutic potential of ozone intraperitoneal injection in an Alzheimer's disease mouse model.
- To evaluate the effects of ozone on cognitive function and AD-related neuropathology.
Main Methods:
- APP/PS1 transgenic mice received daily intraperitoneal injections of ozone (30 or 50 μg/ml) or abdominocentesis for 25 days.
- Cognitive function was assessed using the Morris water maze and open field test.
- Levels of amyloid-beta precursor protein (APP) and other AD biomarkers were measured via ELISA, Western blot, and immunohistochemistry.
Main Results:
- Ozone treatment significantly ameliorated behavioral deficits in APP/PS1 mice, improving spatial learning-memory and reducing anxiety.
- Ozone administration led to a reduction in amyloid-beta precursor protein (APP) levels in the prefrontal cortex and hippocampus.
- Pathological deterioration associated with Alzheimer's disease was alleviated by ozone treatment.
Conclusions:
- Ozone intraperitoneal injection demonstrates therapeutic potential for Alzheimer's disease.
- Ozone therapy may mitigate cognitive decline and reduce key pathological hallmarks of AD.
- Further research into ozone administration as an AD treatment is warranted.
Related Concept Videos
Feedback Inhibition
Transgenic Organisms
Cognitive Dissonance
Enzyme Inhibition
Transgenic Plants
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Language and Cognition

